Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Ads

You May Also Like

FIT Biotech Oy: Chairman of the board on leave of absence

FIT Biotech Oy                                                             Company release 16.8.2018 at 04:00 PM EET Chairman of the board ...

iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer

iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, ...